These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 17196035)

  • 1. Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches.
    Mac Gabhann F; Popel AS
    PLoS Comput Biol; 2006 Dec; 2(12):e180. PubMed ID: 17196035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
    Nassehi D
    Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
    Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M
    Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropilin-1 modulates vascular endothelial growth factor-induced poly(ADP-ribose)-polymerase leading to reduced cerebrovascular apoptosis.
    Mey L; Hörmann M; Schleicher N; Reuter P; Dönges S; Kinscherf R; Gassmann M; Gerriets T; Al-Fakhri N
    Neurobiol Dis; 2013 Nov; 59():111-25. PubMed ID: 23816753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle.
    Mac Gabhann F; Popel AS
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H459-74. PubMed ID: 16980341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
    Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
    Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies.
    Finley SD; Engel-Stefanini MO; Imoukhuede PI; Popel AS
    BMC Syst Biol; 2011 Nov; 5():193. PubMed ID: 22104283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells.
    Fons P; Herault JP; Delesque N; Tuyaret J; Bono F; Herbert JM
    J Cell Physiol; 2004 Sep; 200(3):351-9. PubMed ID: 15254962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model.
    Mac Gabhann F; Popel AS
    Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2851-60. PubMed ID: 15708957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
    Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
    Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropilin-1 participates in wound angiogenesis.
    Matthies AM; Low QE; Lingen MW; DiPietro LA
    Am J Pathol; 2002 Jan; 160(1):289-96. PubMed ID: 11786422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation.
    Halder JB; Zhao X; Soker S; Paria BC; Klagsbrun M; Das SK; Dey SK
    Genesis; 2000 Mar; 26(3):213-24. PubMed ID: 10705382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
    Starzec A; Miteva MA; Ladam P; Villoutreix BO; Perret GY
    Bioorg Med Chem; 2014 Aug; 22(15):4042-8. PubMed ID: 24961874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of growth factor-receptor systems from molecular-level protein interaction networks to whole-body compartment models.
    Wu FTH; Stefanini MO; Gabhann FM; Popel AS
    Methods Enzymol; 2009; 467():461-497. PubMed ID: 19897104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.
    Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A
    Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
    Oh H; Takagi H; Otani A; Koyama S; Kemmochi S; Uemura A; Honda Y
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):383-8. PubMed ID: 11756651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis.
    Bender RJ; Mac Gabhann F
    BMC Syst Biol; 2015 Sep; 9():55. PubMed ID: 26341082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies.
    Chung JY; Song Y; Wang Y; Magness RR; Zheng J
    J Clin Endocrinol Metab; 2004 May; 89(5):2484-90. PubMed ID: 15126581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity.
    Teran M; Nugent MA
    J Biol Chem; 2015 Jun; 290(26):16451-62. PubMed ID: 25979342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.